Does microparticle size affect bland embolization outcomes of local treatment for liver malignancies?

Vascular Disease Management

Volumn 6, Issue 5, 2009, Pages 129-134

  Bonomo, Guido ^a   Monfardini, Lorenzo ^a   Della Vigna, Paolo ^a   Orgera, Gianluigi ^a   Pedicini, Vittorio ^a   Orsi, Frank ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN COATED MICROSPHERE; DEXTRAN MICROSPHERE; EMBOSPHERE MICROSPHERE; EMBOZENE MICROSPHERE; GELATIN SPONGE; GELFOAM; IRON OXIDE; MICROSPHERE; POLY(METHYL METHACRYLATE); POLYMER; POLYSTYRENE; POLYVINYL ALCOHOL MICROSPHERE; POLYVINYL ALCOHOL SPONGE; POLYZENE F; TRISACRYL GELATIN MICROSPHERE; UNCLASSIFIED DRUG;

ARTIFICIAL EMBOLISM; BLAND EMBOLIZATION; BLOOD VESSEL DIAMETER; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DRUG COATING; DRUG DISTRIBUTION; GIANT CELL; HISTOPATHOLOGY; HUMAN; HYDROGEL; INFLAMMATION; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; LUNG EMBOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; REVIEW; SELECTIVE INTERNAL RADIATION THERAPY; TECHNIQUE; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

EID: 70349932124     PISSN: 15538036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Alba E, Valls C, Dominguez J, et al. Trancatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. AJR 2008;190:1341-1348. (Pubitemid 351684928)
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750. (Pubitemid 29114292)
4. El-Serag HB, Davial JA, Petersen N, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann Intern Med 2003;139:817-823.
5. Brachet D, Lermite E, Rouquette A, et al. Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: Review of sixty-two cases treated at a single insititution. Dis Colon Rectum 2009;52:475-483.
6. Jack CR, Forbes G, Dewanjee MK, et al. Poly-vinyl alcohol sponge for embolotherapy: Particle size and morphology. Am J Neuroradil 1985;6:595-597. (Pubitemid 15070046)
7. Derdeyn C, Moran C, Cross D, et al. Polyvynil alcohol particle size and suspension characteristics. Am J Neuroradil 1995;16:1335-1343.
8. Laurent A, Beaujex R, Wassef M, et al. Trisacryl gelatin microspheres for the therapeutic embolization, I: Development and in vitro evaluation. Am J Neuroradiol 1996;17:533-540. (Pubitemid 26101959)
9. Derdeyn CP, Graves VB, Salamat MS, et al. Collagen-coated acrylic microspheres for embolotherapy: In vivo and in vitro characteristics. Am J Neuroradiol 1997;18:647-653.
10. Dion JE, Raniìkin RN, Vinuela F, et al. Dextran microsphere embolization: Experimental and clinical experience with radiologic-pathologic correlation. Work in progress. Radiology 1986;160:717-721. (Pubitemid 16044042)
11. Siskin GP, Dowling K, Virmani R, et al. Pathologic evaluation of spherical polyvinyl alcohol embolic agent in a porcine renal model. J Vasc Interv Radiol 2003;14:89-98. (Pubitemid 36134079)
12. Maluccio MA, Covey AM, Porat LB, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2008;19:862-869.
13. Poggi G, Quaretti P, Minoia C, et al. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Anticancer Res 2008;28(6B):3835-3842.
14. Grosso M, Vignali C, Quaretti P, et al. Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: Preliminary results from an Italian multicentre study. Cardiovasc Interv Radiol 2008;31:1141-1149.
15. Laurent A, Wassef M, Chapot R, et al. Location of vessel occlusion of calibrated tris-acryl gelatin microspheres for tumor and arteriovenous malformation embolization. J Vasc Radiol 2004;15:491-496. (Pubitemid 38590874)
16. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-977.
17. Miraglia R, Pietrosi G, Maruzzelli L, et al. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol 2007;13:2952-2955. (Pubitemid 47028883)
18. Breedis C, Young G, Luckè B. Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Unpublished data.
19. Healey JE. Vascular patterns in human metastatic liver tumors. Surg Gyn Obs 1965;120:1187-1194.
20. Lin G, Lunderquist A, Hagerstrand I, et al. Postmortem examination of the bloodsupply and vascular pattern of small liver metastases in man. Surgery 1984;96:517-526. (Pubitemid 14067500)
21. Taylor I, Bennet R, Sherriff S. The blood supply of colorectal liver metastases. Br J Cancer 1978;38:749-756. (Pubitemid 9086487)
22. Ackerman NB, Hodgson WB. Vascular patterns of liver tumors and their consequences for different therapeutic approaches. Recent results. Cancer Res 1986;100:248-255
23. Nilsson LA. Therapeutic hepatic artery ligation in patients with secondary liver tumors. Rev Surg 1966;23:374-376.
24. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-1118.
25. Lau Wy, Ho S, Leung TWT, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intrarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998;40:583-592. (Pubitemid 28104228)
26. Maluccio M, Covey AM, Gandhi R, et al. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 2005;16:955-961. (Pubitemid 40993518)
27. Herman B, Nieminem AL, Gore GJ, et al. Irreversible injury in anoxic hepatocytes precipitated by an abrupt increase in plasma membrane permeability. The FASEB Journal 1988;2:146-151.
28. Pillai KM, McKeever PE, Knutsen CA, et al. Microscopic analysis of arterial microsphere distribution in rabbit liver and hepatic VX2 tumor. Sel Cancer Ther 1991;7:39-48.
29. Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, et al. Scanning electorn microscopy study of the blood supply of human colorectal liver metastases. EJSO 2003;29;856-861. (Pubitemid 37493284)
30. Liapi E, Geschwind JFH. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 2007;25:978-986. (Pubitemid 350002864)
31. Lee KH, Liapi E, Vossen JA, et al. Distribution of iron oxide-containing embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: Evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol 2008;19:1490-1496.
32. Ohlsson B, Lindell G, Lundstedt C, et al. Dearterialization of colorectal liver cancer: Institutional experience. Dig Surg 1999;16:229-235. (Pubitemid 29361289)
33. Taniguchi H, Daidoh T, Shioaki Y, et al. Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling. Cancer 1993;71:50-55. (Pubitemid 23019280)
34. Kan Z, Ivancev K, Lunderquist A, et al. In vivo microscopi of hepatic tumors in animal models: A dinamic investigation of blood supply to hepatic metastases. Radiology 1993;187:621-626. (Pubitemid 23155684)
35. Jones JA, Chang DT, Meyerson H, et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 2007;83:585-596. (Pubitemid 350086284)
36. Stampfl S, Stampfl U, Bellemann N, et al. Experimental liver embolization with four different spherical embolic materials: Impact on inflammatory tissue and foreign body reaction. Cardiovasc Intervent Radiol 2009;32:303-312.
37. Brown KT. Fatal pulmonary complications after arterial embolization with 40-120 μm tris-acryl gelatine microspheres. J Vasc Interv Radiol 2004;15:197-200. (Pubitemid 38248922)
38. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 2006;17:1251-1278. (Pubitemid 44259009)
39. Lopez-Benitez R, Richter GM, Kauczor HU, et al. Analysis of nontarget embolization mechanisms during embolization and chemoembolization procedures. Cardiovasc Intervent Radiol 2009;32:615-622.